126 related articles for article (PubMed ID: 12127435)
1. Ribavirin and interferon combination for recurrent post-transplant hepatitis C: which benefit beyond 6 months?
Bizollon T; Trepo C
J Hepatol; 2002 Aug; 37(2):274-6. PubMed ID: 12127435
[No Abstract] [Full Text] [Related]
2. Recurrent hepatitis C genotype 1b following liver transplantation: treatment with combination interferon-ribavirin therapy.
Berenguer M; Prieto M; Palau A; Carrasco D; Rayón JM; Calvo F; Berenguer J
Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1207-12. PubMed ID: 15489583
[TBL] [Abstract][Full Text] [Related]
3. [What therapy is meaningful in chronic hepatitis C and resection of hepatocellular carcinoma for recurrence prophylaxis?].
Malfertheiner P
Dtsch Med Wochenschr; 2002 Nov; 127(48):2580. PubMed ID: 12457331
[No Abstract] [Full Text] [Related]
4. Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin.
Lavezzo B; Franchello A; Smedile A; David E; Barbui A; Torrani M; Ottobrelli A; Zamboni F; Fadda M; Bobbio A; Salizzoni M; Rizzetto M
J Hepatol; 2002 Aug; 37(2):247-52. PubMed ID: 12127430
[TBL] [Abstract][Full Text] [Related]
5. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
Jessner W; Der-Petrossian M; Christiansen L; Maier H; Steindl-Munda P; Gangl A; Ferenci P
Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
[No Abstract] [Full Text] [Related]
6. Combination treatment with interferon and ribavirin for chronic hepatitis C.
Davis GL
Clin Liver Dis; 1999 Nov; 3(4):811-26. PubMed ID: 11291252
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
Alberti AB; Belli LS; Airoldi A; de Carlis L; Rondinara G; Minola E; Vangeli M; Cernuschi A; D'Amico M; Forti D; Pinzello G
Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985
[TBL] [Abstract][Full Text] [Related]
8. Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection.
Lin TY; Yeh ML; Huang CI; Chen YL; Dai CY; Huang JF; Lin ZY; Chen SC; Huang CF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Jun; 33(6):284-289. PubMed ID: 28601232
[TBL] [Abstract][Full Text] [Related]
9. [Combination therapy of interferon plus ribavirin for chronic hepatitis C].
Asahina Y; Izumi N
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):467-73. PubMed ID: 15359843
[No Abstract] [Full Text] [Related]
10. Maintenance ribavirin monotherapy: the case for post-transplantation recurrent hepatitis C.
Trepo C; Bailly F
Dig Liver Dis; 2010 Apr; 42(4):283-4. PubMed ID: 20189473
[No Abstract] [Full Text] [Related]
11. What offers the best prediction of sustained virologic response during combination therapy with interferon and ribavirin: viral dynamics, viral levels at certain time points, or a combination of both?
Weiland O
J Hepatol; 2009 Jul; 51(1):4-7. PubMed ID: 19446915
[No Abstract] [Full Text] [Related]
12. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
[TBL] [Abstract][Full Text] [Related]
13. Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection.
Beckebaum S; Cicinnati VR; Karliova M; Dirsch O; Erim Y; Frilling A; Malago M; Broelsch CE; Treichel U; Gerken G
Transplant Proc; 2003 Sep; 35(6):2080-1. PubMed ID: 14529846
[No Abstract] [Full Text] [Related]
14. Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy.
Narayanan Menon KV; Poterucha JJ; El-Amin OM; Burgart LJ; Kremers WK; Rosen CB; Wiesner RH; Charlton M
Liver Transpl; 2002 Jul; 8(7):623-9. PubMed ID: 12089717
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent hepatitis C following liver transplantation.
Bizollon T; Ducerf C; Baulieux J; Trepo C
Curr Gastroenterol Rep; 1999; 1(1):15-9. PubMed ID: 10980921
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.
Abdelmalek MF; Liu C; Valentine JF
Am J Gastroenterol; 2007 Jun; 102(6):1333-4. PubMed ID: 17531027
[No Abstract] [Full Text] [Related]
17. Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C.
Vigani AG; Pavan MH; Tozzo R; Gonçales ES; Lazarini MS; Oliveira AM; Gonçales FL
Braz J Infect Dis; 2010; 14(2):193-6. PubMed ID: 20563450
[TBL] [Abstract][Full Text] [Related]
18. A modified ribavirin-free interferon therapy with boceprevir in post-liver transplant recurrent hepatitis C.
Maticic M; Luznik Z; Stepec S; Popovic P; Snedec N; Poljak M; Stanisavljevic D
J Clin Gastroenterol; 2014; 48(5):464-5. PubMed ID: 24275712
[No Abstract] [Full Text] [Related]
19. [Future outlook for treatment of chronic hepatitis C: IFN + ribavirin combination therapy].
Iino S
Rinsho Byori; 2001 Aug; 49(8):747-54. PubMed ID: 11573281
[TBL] [Abstract][Full Text] [Related]
20. [Differential effects of interferon-based treatments in chronic hepatitis C].
Nakamoto Y; Kaneko S
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):485-7. PubMed ID: 15359846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
